In accordance with the requirements of the FSA (Voluntary Self-Monitoring of the Pharmaceutical Industry), the conditions and the extent of the support of member companies should be presented transparently to the participants both in the congress announcement and in the implementation of the congress.

According to the guidelines of the AKG (Arzneimittel und Kooperation im Gesundheitswesen e.V.), member companies should work towards ensuring that their support is disclosed by the organiser both in the announcement of the congress and in its implementation. The publication of the type and extent of the total support does not constitute an obligation for the AKG member companies and takes place here voluntarily after written consent.

For the industrial partners named below, we provide information about their overall support within the framework of ENDOCLUBNORD 2023 in accordance with their membership in the FSA or AKG or individual consent: